NL-OMON39920撤回不适用
Response to pneumococcal en Hib vaccination in lymphoma patients treated with chemotherapy and rituximab. - PNEUMOTUXIVAC
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 入组人数
- 152
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Patients with non-Hodgkin*s lymphoma, treated with rituximab (with a range of 6-12 cycles) and who are in remission.
- •2. Completion of rituximab therapy in the last five months before start of the study.
- •3. Age * 18 years.
- •4. Signing of informed consent.
排除标准
- •1. Completion of rituximab therapy >5-6 months before start of the study.
- •2. Fever at time of vaccination.
- •3. Previous/known allergic reaction to any of the components of the vaccines given.
- •4. Vaccination with Hib or pneumococcal vaccine in the last fifteen months before start of the study
研究者
相似试验
尚未招募
不适用
Respons to vaccination in patients with cancer of the lympfnodes who are treated with chemotherapy.NL-OMON27098St. Antonius Ziekenhuis152
进行中（未招募）
不适用
Immune response to pneumococcal conjugate vaccine in adults receiving hepatitis A vaccine concomitantly18 years old or older volunteers with general good healthEUCTR2012-003484-22-FIHelsinki University Central Hospital600
进行中（未招募）
不适用
Immune response to pneumococcal conjugate vaccine in adults receiving hepatitis A vaccine concomitantlyEUCTR2012-003484-22-SEHelsinki University Central Hospital300
招募中
不适用
De antistof respons na pneumokokkenvaccinatie bij IBD-patiënten die behandeld worden met immunosuppressiva – de PNEUMOREACT studieinflammatory bowel disease (inflammatoire darmziekte)immunosuppressive agents (immunosuppressiva)pneumococcal vaccination (pneumokokkenvaccinatie)vaccine immunogenicity (vaccin immunogeniciteit)NL-OMON29135Academic Medical Center188
已完成
4 期
The antibody response to pneumococcal vaccination in patients with inflammatory bowel disease patients treated with immunosuppressive agentsantibody responseprotection after vaccination1001796910027665NL-OMON45696Academisch Medisch Centrum178